Cargando…

Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration

BACKGROUND: Monocarboxylate transporter 1 (MCT1) is a regulator of cell metabolism and a therapeutic target for cancer treatment. Understanding the changes in tumour function accompanying MCT1 inhibition will better characterise the anti-tumour effects of MCT1 inhibitors, potentially enabling the id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beloueche-Babari, Mounia, Casals Galobart, Teresa, Delgado-Goni, Teresa, Wantuch, Slawomir, Parkes, Harold G., Tandy, Debbie, Harker, James A., Leach, Martin O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078321/ https://www.ncbi.nlm.nih.gov/pubmed/31937921 http://dx.doi.org/10.1038/s41416-019-0717-x

Ejemplares similares

Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells
por: Delgado-Goñi, Teresa, et al.
Publicado: (2019)

Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imaging
por: Shah, Anant, et al.
Publicado: (2017)

Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965
por: Braga, Marta, et al.
Publicado: (2020)

In Vivo Anticancer Activity of AZD3965: A Systematic Review
por: Silva, Ana, et al.
Publicado: (2021)

A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965
por: McNeillis, Rosie, et al.
Publicado: (2020)

In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment
por: Benyahia, Zohra, et al.
Publicado: (2021)

Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition
por: Beloueche-Babari, Mounia, et al.
Publicado: (2010)

Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965
por: McNeillis, Rosie, et al.
Publicado: (2020)

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI
por: Beloueche-Babari, M, et al.
Publicado: (2013)

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity
por: Curtis, Nicola J., et al.
Publicado: (2017)

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
por: Noble, Richard A., et al.
Publicado: (2017)

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
por: Hanson, Derek James, et al.
Publicado: (2015)

Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy
por: Beloueche-Babari, M, et al.
Publicado: (2010)

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
por: Beloueche-Babari, M, et al.
Publicado: (2015)

Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized (13)C Magnetic Resonance Spectroscopy Data
por: Hill, Deborah K., et al.
Publicado: (2013)

The LXR ligand GW3965 inhibits Newcastle disease virus infection by affecting cholesterol homeostasis
por: Sheng, Xiang-xiang, et al.
Publicado: (2016)

Monocarboxylate transporters in cancer
por: Payen, Valéry L., et al.
Publicado: (2019)

Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis
por: Koh, King Xin, et al.
Publicado: (2017)

Monocarboxylate transporters in the brain and in cancer()
por: Pérez-Escuredo, Jhudit, et al.
Publicado: (2016)

A monocarboxylate transporter rescues frontotemporal dementia and Alzheimer’s disease models
por: Xu, Dongwei, et al.
Publicado: (2023)

Monocarboxylate Transporters: Role and Regulation in Corneal Diabetes
por: Shrestha, Pawan, et al.
Publicado: (2022)

Monocarboxylate transporter expression at the onset of skeletal muscle regeneration
por: Washington, Tyrone A, et al.
Publicado: (2013)

Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
por: Vancamp, Pieter, et al.
Publicado: (2020)

Cooperative transport mechanism of human monocarboxylate transporter 2
por: Zhang, Bo, et al.
Publicado: (2020)

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)

Distribution of Monocarboxylate Transporters in Brain and Choroid Plexus Epithelium
por: Ueno, Masaki, et al.
Publicado: (2023)

The Liver X Receptor Agonist GW3965 Improves Recovery from Mild Repetitive Traumatic Brain Injury in Mice Partly through Apolipoprotein E
por: Namjoshi, Dhananjay R., et al.
Publicado: (2013)

Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells
por: Guo, Chen, et al.
Publicado: (2019)

AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways
por: Yin, Wei, et al.
Publicado: (2021)

Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells
por: Ronen, S M, et al.
Publicado: (2001)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
por: Hu, Yong, et al.
Publicado: (2017)

Monocarboxylate Transporters and Lactate Metabolism in Equine Athletes: A Review
por: Pösö, AR
Publicado: (2002)

Tissue-Specific Expression of Monocarboxylate Transporters during Fasting in Mice
por: Schutkowski, Alexandra, et al.
Publicado: (2014)

The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors
por: Silva, Eduardo C.A., et al.
Publicado: (2018)

Reduction of epileptiform activity in ketogenic mice: The role of monocarboxylate transporters
por: Forero-Quintero, Linda S., et al.
Publicado: (2017)

The transport mechanism of monocarboxylate transporter on spinosin in Caco-2 cells
por: Meng, Xiang Le, et al.
Publicado: (2016)

Astrocytes and neurons communicate via a monocarboxylic acid shuttle
por: Roosterman, Dirk, et al.
Publicado: (2020)

Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment
por: van Geest, Ferdy S., et al.
Publicado: (2021)

Visual analysis on the research of monocarboxylate transporters based on CiteSpace
por: Li, Feifei, et al.
Publicado: (2021)

Monocarboxylate Transporters 1 and 4 and MTCO1 in Gastric Cancer
por: Eskuri, Maarit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9v2pj2l56lqcjo5s1i4qs885f1